1
|
Toscanini U, Gusmão L, Álava Narváez MC, Álvarez JC, Baldassarri L, Barbaro A, Berardi G, Betancor Hernández E, Camargo M, Carreras-Carbonell J, Castro J, Costa SC, Coufalova P, Domínguez V, Fagundes de Carvalho E, Ferreira STG, Furfuro S, García O, Goios A, González R, de la Vega AG, Gorostiza A, Hernández A, Jiménez Moreno S, Lareu MV, León Almagro A, Marino M, Martínez G, Miozzo MC, Modesti NM, Onofri V, Pagano S, Pardo Arias B, Pedrosa S, Penacino GA, Pontes ML, Porto MJ, Puente-Prieto J, Pérez RR, Ribeiro T, Rodríguez Cardozo B, Rodríguez Lesmes YM, Sala A, Santiago B, Saragoni VG, Serrano A, Streitenberger ER, Torres Morales MA, Vannelli Rey SA, Velázquez Miranda M, Whittle MR, Fernández K, Salas A. Analysis of uni and bi-parental markers in mixture samples: Lessons from the 22nd GHEP-ISFG Intercomparison Exercise. Forensic Sci Int Genet 2016; 25:63-72. [PMID: 27500650 DOI: 10.1016/j.fsigen.2016.07.010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 07/14/2016] [Accepted: 07/17/2016] [Indexed: 10/21/2022]
Abstract
Since 1992, the Spanish and Portuguese-Speaking Working Group of the ISFG (GHEP-ISFG) has been organizing annual Intercomparison Exercises (IEs) coordinated by the Quality Service at the National Institute of Toxicology and Forensic Sciences (INTCF) from Madrid, aiming to provide proficiency tests for forensic DNA laboratories. Each annual exercise comprises a Basic (recently accredited under ISO/IEC 17043: 2010) and an Advanced Level, both including a kinship and a forensic module. Here, we show the results for both autosomal and sex-chromosomal STRs, and for mitochondrial DNA (mtDNA) in two samples included in the forensic modules, namely a mixture 2:1 (v/v) saliva/blood (M4) and a mixture 4:1 (v/v) saliva/semen (M8) out of the five items provided in the 2014 GHEP-ISFG IE. Discrepancies, other than typos or nomenclature errors (over the total allele calls), represented 6.5% (M4) and 4.7% (M8) for autosomal STRs, 15.4% (M4) and 7.8% (M8) for X-STRs, and 1.2% (M4) and 0.0% (M8) for Y-STRs. Drop-out and drop-in alleles were the main cause of errors, with laboratories using different criteria regarding inclusion of minor peaks and stutter bands. Commonly used commercial kits yielded different results for a micro-variant detected at locus D12S391. In addition, the analysis of electropherograms revealed that the proportions of the contributors detected in the mixtures varied among the participants. In regards to mtDNA analysis, besides important discrepancies in reporting heteroplasmies, there was no agreement for the results of sample M4. Thus, while some laboratories documented a single control region haplotype, a few reported unexpected profiles (suggesting contamination problems). For M8, most laboratories detected only the haplotype corresponding to the saliva. Although the GHEP-ISFG has already a large experience in IEs, the present multi-centric study revealed challenges that still exist related to DNA mixtures interpretation. Overall, the results emphasize the need for further research and training actions in order to improve the analysis of mixtures among the forensic practitioners.
Collapse
Affiliation(s)
- U Toscanini
- PRICAI-Fundación Favaloro, Buenos Aires, Argentina.
| | - L Gusmão
- DNA Diagnostic Laboratory (LDD), State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil; IPATIMUP (Institute of Pathology and Molecular Immunology from de University of Porto), Porto, Portugal; I3s (Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Porto, Portugal
| | - M C Álava Narváez
- Laboratorio de Genética Regional Bogotá del Instituto Nacional de Medicina Legal y Ciencias Forenses., Bogotá, Colombia
| | - J C Álvarez
- Lab. de Identificación Genética. Depto. de Medicina Legal, Toxicología y Antropología Física. Facultad de Medicina. Universidad de Granada, Granada, Spain
| | - L Baldassarri
- Institute of Public Sanity Section of Legal Medicine Catholic University of Sacred Heart, Rome, Rome, Italy
| | - A Barbaro
- Studio Indagini Mediche E Forensi (SIMEF), Reggio Calabria, Italy
| | - G Berardi
- PRICAI-Fundación Favaloro, Buenos Aires, Argentina
| | - E Betancor Hernández
- Laboratorio Genética Forense, Instituto de Medicina Legal de Las Palmas, ULPG., Las Palmas, Spain
| | - M Camargo
- Laboratorio de Genética Regional Suroccidente del Instituto Nacional de Medicina Legal y Ciencias Forenses., Cali, Colombia
| | - J Carreras-Carbonell
- Policia de la Generalitat - Mossos d'Esquadra, Divisió de Policia Científica, Unitat Central del Laboratori Biològic, Sabadell, Barcelona, Spain
| | - J Castro
- Genética Forense, Unidad Criminalistica Contra la Vulneración de Derechos Fundamentales, Ministerio Público, Venezuela
| | - S C Costa
- Laboratório de Polícia Científica da Polícia Judiciária, Lisbon, Portugal
| | - P Coufalova
- Institute of Criminalistics Prague, Prague, Czech Republic
| | - V Domínguez
- Lab. Biológico de la Dirección Nacional de Policía Científica, Montevideo, Uruguay
| | - E Fagundes de Carvalho
- DNA Diagnostic Laboratory (LDD), State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil
| | - S T G Ferreira
- Instituto de Pesquisa de DNA Forense, IPDNA, Polícia Civil do Distrito Federal, PCDF, Brasília, Brazil, and Secretaria Nacional de Segurança Pública do Ministério da Justiça, SENASP/MJ, Brasília, Brazil
| | - S Furfuro
- Laboratorio de Análisis de ADN- Facultad de Ciencias Médicas- Universidad Nacional de Cuyo, Mendoza, Argentina
| | - O García
- Forensic Science Unit, Forensic Genetics Section, Basque Country Police-Ertzaintza, Erandio, Bizkaia, Spain
| | - A Goios
- IPATIMUP (Institute of Pathology and Molecular Immunology from de University of Porto), Porto, Portugal; I3s (Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Porto, Portugal
| | - R González
- Registro Nacional de ADN, Chile, Santiago de Chile, Chile
| | | | | | - A Hernández
- Instituto Nacional de Toxicología y Ciencias Forenses, Delegación en Canarias, Santa Cruz de Tenerife, Spain
| | - S Jiménez Moreno
- Laboratorio de Biología Forense. Dpto Patología y Cirugía. Universidad Miguel Hernández, Elche, Alicante, Spain
| | - M V Lareu
- Unidade de Xenética, Departamento de Anatomía Patolóxica e Ciencias Forenses, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, and GenPop Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago, Galicia, Spain
| | - A León Almagro
- Comisaría General de Policía Científica - Laboratorio de ADN, Madrid, Spain
| | - M Marino
- Laboratorio de Genética Forense, Poder Judicial de Mendoza, Mendoza, Argentina
| | - G Martínez
- Servicio de Genética Forense, Superior Tribunal de Justicia de Entre Ríos, Paraná, Argentina
| | - M C Miozzo
- Laboratorio Regional de Genética Forense del NOA - Departamento Médico - Poder Judicial de Jujuy, Jujuy, Argentina
| | - N M Modesti
- Instituto de Genética Forense. Poder Judicial de Córdoba, Córdoba, Argentina
| | - V Onofri
- Universita' Politecnica Delle Marche, DSBSP, Section of Legal Medicine, Ancona, Italy
| | | | - B Pardo Arias
- Instituto Nacional de Toxicología y Ciencias Forenses, Departamento de Sevilla, Sevilla, Spain
| | | | - G A Penacino
- Unidad de Analisis de ADN, Colegio Oficial de Farmaceuticos y Bioquímicos, Buenos Aires, Argentina
| | - M L Pontes
- Serviço de Genética e Biologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses, I.P. - Delegação do Norte, Porto, Portugal
| | - M J Porto
- Serviço de Genética e Biologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses, I.P., Coimbra, Portugal
| | - J Puente-Prieto
- LabGenetics. Laboratorio de Genética Clínica S.L., Madrid, Spain
| | | | - T Ribeiro
- Serviço de Genética e Biologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses, I.P.-Delegação Sul, Lisbon, Portugal
| | | | - Y M Rodríguez Lesmes
- Laboratorio de Biología y Genética Regional Noroccidente del Instituto Nacional de Medicina Legal y Ciencias Forenses., Medellín, Colombia
| | - A Sala
- Servicio de Huellas Digitales Genéticas-Fac. Farmacia y Bioquímica-Universidad de Buenos Aires, Buenos Aires, Argentina
| | - B Santiago
- Instituto Nacional de Toxicología y Ciencias Forenses, Departamento de Madrid. Servicio de Biología., Madrid, Spain
| | - V G Saragoni
- Unidad de Genética Forense, Servicio Médico Legal, Santiago, Chile
| | - A Serrano
- Instituto Nacional de Toxicología y Ciencias Forenses, Departamento de Barcelona, Barcelona, Spain
| | | | | | - S A Vannelli Rey
- Laboratorio Regional Patagonia Norte de Genética Forense - Poder Judicial de Río Negro, Bariloche, Argentina
| | | | - M R Whittle
- Genomic Engenharia Molecular, Sao Paulo, Brazil
| | - K Fernández
- Instituto Nacional de Toxicología y Ciencias Forenses, Departamento de Madrid. Servicio de Biología., Madrid, Spain
| | - A Salas
- Unidade de Xenética, Departamento de Anatomía Patolóxica e Ciencias Forenses, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, and GenPop Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago, Galicia, Spain
| |
Collapse
|
2
|
Rodrigues AL, Carvalho A, Cabral R, Carneiro V, Gilardi P, Duarte CP, Puente-Prieto J, Santos P, Mota-Vieira L. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation. Genet Mol Res 2014; 13:5654-63. [PMID: 25117323 DOI: 10.4238/2014.july.25.21] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Gorlin-Goltz syndrome, or nevoid basal cell carcinoma syndrome (NBCCS), is a rare autosomal dominant disorder caused by mutations in the PTCH1 gene and shows a high level of penetrance and variable expressivity. The syndrome is characterized by developmental abnormalities or neoplasms and is diagnosed with 2 major criteria, or with 1 major and 2 minor criteria. Here, we report a new clinical manifestation associated with this syndrome in a boy affected by NBCCS who had congenital orbital teratoma at birth. Later, at the age of 15 years, he presented with 4 major and 4 minor criteria of NBCCS, including multiple basal cell carcinoma and 2 odontogenic keratocysts of the jaw, both confirmed by histology, more than 5 palmar pits, calcification of the cerebral falx, extensive meningeal calcifications, macrocephaly, hypertelorism, frontal bosses, and kyphoscoliosis. PTCH1 mutation analysis revealed the heterozygous germline mutation c.290dupA. This mutation generated a frameshift within exon 2 and an early premature stop codon (p.Asn97LysfsX43), predicting a truncated protein with complete loss of function. Identification of this mutation is useful for genetic counseling. Although the clinical symptoms are well-known, our case contributes to the understanding of phenotypic variability in NBCCS, highlighting that PTCH1 mutations cannot be used for predicting disease burden and reinforces the need of a multidisciplinary team in the diagnosis, treatment, and follow-up of NBCCS patients.
Collapse
Affiliation(s)
- A L Rodrigues
- Serviço de Pediatria, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - A Carvalho
- Serviço de Pediatria, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - R Cabral
- Unidade de Genética e Patologia Moleculares, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - V Carneiro
- Serviço de Anatomia Patalógica, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - P Gilardi
- LabGenetics, Laboratorio de Genetica Clinica S.L. San Sebastián de los Reyes, Madrid, Spain
| | - C P Duarte
- Serviço de Pediatria, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - J Puente-Prieto
- LabGenetics, Laboratorio de Genetica Clinica S.L. San Sebastián de los Reyes, Madrid, Spain
| | - P Santos
- Serviço de Dermatologia, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| | - L Mota-Vieira
- Unidade de Genética e Patologia Moleculares, Hospital do Divino Espírito Santo de Ponta Delgada, EPE, Açores, Portugal
| |
Collapse
|